CRSP CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

$107.72  -0.12 (-0.11%)
As of 05/07/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  10/19/2016
Outstanding shares:  75,768,936
Average volume:  1,568,007
Market cap:   $8,630,081,810
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    H17182108
ISIN:        CH0334081137
Sedol:      BDHF4K6
Valuation   (See tab for details)
PE ratio:   -20.83
PB ratio:   4.52
PS ratio:   0.00
Return on equity:   -21.73%
Net income %:   -35,630.97%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy